Clinical Trial Update: Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating combination chemotherapy as induction therapy for stage III non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED